NanoViricides
NNVC
#10106
Rank
A$50.98 M
Marketcap
A$2.24
Share price
5.30%
Change (1 day)
-1.49%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: A$50.98 Million

As of May 2026 NanoViricides has a market cap of A$50.98 Million. This makes NanoViricides the world's 10106th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026A$50.98 M33.05%
2025A$38.31 M10.75%
2024A$34.59 M96.75%
2023A$17.58 M-7.14%
2022A$18.93 M-67.98%
2021A$59.13 M48.56%
2020A$39.8 M186.87%
2019A$13.87 M-29.68%
2018A$19.73 M-72.36%
2017A$71.39 M-17.36%
2016A$86.39 M-7.75%
2015A$93.66 M-50.18%
2014A$0.18 B-30.19%
2013A$0.26 B274.01%
2012A$72 M-18.96%
2011A$88.84 M-55.77%
2010A$0.20 B60.92%
2009A$0.12 B-11.4%
2008A$0.14 B165.05%
2007A$53.15 M

End of Day market cap according to different sources

On May 19th, 2026 the market cap of NanoViricides was reported to be:

A$48.14 Million
by Nasdaq info icon info icon
A$50.98 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
A$228.06 B 447,226.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$397.15 B 778,881.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$167.60 B 328,643.16%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$144.19 B 282,724.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
A$2.06 B 3,940.50%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$3.13 B 6,053.95%๐Ÿ‡บ๐Ÿ‡ธ USA